Pharma Foods International Co., Ltd. (TYO:2929)
917.00
+10.00 (1.10%)
May 2, 2025, 3:30 PM JST
TYO:2929 Balance Sheet
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 11,106 | 15,666 | 16,306 | 8,845 | 9,794 | 3,282 | Upgrade
|
Cash & Short-Term Investments | 11,106 | 15,666 | 16,306 | 8,845 | 9,794 | 3,282 | Upgrade
|
Cash Growth | -34.67% | -3.92% | 84.35% | -9.69% | 198.42% | -23.96% | Upgrade
|
Accounts Receivable | 4,090 | 4,294 | 4,582 | 7,425 | 4,917 | 2,236 | Upgrade
|
Receivables | 4,090 | 4,294 | 4,582 | 7,425 | 4,917 | 2,236 | Upgrade
|
Inventory | 6,886 | 6,717 | 6,053 | 6,066 | 2,748 | 1,677 | Upgrade
|
Other Current Assets | 1,231 | 598 | 589 | 1,177 | 474 | 242 | Upgrade
|
Total Current Assets | 23,313 | 27,275 | 27,530 | 23,513 | 17,933 | 7,437 | Upgrade
|
Property, Plant & Equipment | 4,768 | 4,609 | 4,404 | 4,458 | 1,808 | 1,768 | Upgrade
|
Long-Term Investments | 3,839 | 4,159 | 3,663 | 2,881 | 987 | 637 | Upgrade
|
Goodwill | 91 | 124 | 197 | 270 | 140 | 153 | Upgrade
|
Other Intangible Assets | 48 | 53 | 41 | 35 | 45 | 45 | Upgrade
|
Long-Term Deferred Tax Assets | 915 | 351 | 395 | - | - | - | Upgrade
|
Other Long-Term Assets | 1 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
Total Assets | 32,975 | 36,573 | 36,232 | 31,159 | 20,944 | 10,096 | Upgrade
|
Accounts Payable | 1,156 | 1,250 | 937 | 1,176 | 846 | 449 | Upgrade
|
Accrued Expenses | 81 | 72 | 72 | 70 | 3 | 2 | Upgrade
|
Short-Term Debt | 10,900 | 14,900 | 17,400 | 15,400 | 2,500 | - | Upgrade
|
Current Portion of Long-Term Debt | 593 | 760 | 955 | 760 | 939 | 1,275 | Upgrade
|
Current Income Taxes Payable | 5,952 | 5,423 | 3,992 | 4,511 | 5,283 | 880 | Upgrade
|
Other Current Liabilities | 810 | 758 | 1,018 | 878 | 1,407 | 231 | Upgrade
|
Total Current Liabilities | 19,492 | 23,163 | 24,374 | 22,795 | 10,978 | 2,837 | Upgrade
|
Long-Term Debt | 951 | 1,231 | 1,741 | 697 | 1,458 | 2,302 | Upgrade
|
Other Long-Term Liabilities | 118 | 210 | 167 | 168 | 28 | 30 | Upgrade
|
Total Liabilities | 20,928 | 24,988 | 26,602 | 24,087 | 12,480 | 5,189 | Upgrade
|
Common Stock | 2,043 | 2,043 | 2,043 | 2,042 | 2,038 | 2,033 | Upgrade
|
Additional Paid-In Capital | 1,814 | 1,814 | 1,814 | 1,820 | 1,817 | 1,812 | Upgrade
|
Retained Earnings | 7,915 | 8,356 | 5,792 | 3,300 | 4,599 | 1,048 | Upgrade
|
Treasury Stock | -20 | -1,194 | -343 | -138 | - | - | Upgrade
|
Comprehensive Income & Other | 295 | 566 | 324 | 46 | 10 | 14 | Upgrade
|
Total Common Equity | 12,047 | 11,585 | 9,630 | 7,070 | 8,464 | 4,907 | Upgrade
|
Minority Interest | - | - | - | 2 | - | - | Upgrade
|
Shareholders' Equity | 12,047 | 11,585 | 9,630 | 7,072 | 8,464 | 4,907 | Upgrade
|
Total Liabilities & Equity | 32,975 | 36,573 | 36,232 | 31,159 | 20,944 | 10,096 | Upgrade
|
Total Debt | 12,444 | 16,891 | 20,096 | 16,857 | 4,897 | 3,577 | Upgrade
|
Net Cash (Debt) | -1,338 | -1,225 | -3,790 | -8,012 | 4,897 | -295 | Upgrade
|
Net Cash Per Share | -47.29 | -43.07 | -131.25 | -276.14 | 168.47 | -10.15 | Upgrade
|
Filing Date Shares Outstanding | 29.06 | 28.07 | 28.85 | 29.02 | 28.95 | 29.05 | Upgrade
|
Total Common Shares Outstanding | 29.06 | 28.07 | 28.85 | 29.02 | 29.06 | 29.04 | Upgrade
|
Working Capital | 3,821 | 4,112 | 3,156 | 718 | 6,955 | 4,600 | Upgrade
|
Book Value Per Share | 414.57 | 412.69 | 333.85 | 243.61 | 291.24 | 168.95 | Upgrade
|
Tangible Book Value | 11,908 | 11,408 | 9,392 | 6,765 | 8,279 | 4,709 | Upgrade
|
Tangible Book Value Per Share | 409.79 | 406.38 | 325.60 | 233.10 | 284.87 | 162.14 | Upgrade
|
Order Backlog | - | 1,012 | 1,558 | 1,300 | 63 | 9.47 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.